{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"47.6","value":"7.06"},{"groupId":"OG001","spread":"19.3","value":"138"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Lead-in Period Day -1, predose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"38.1","value":"8.77"},{"groupId":"OG001","spread":"26.0","value":"147"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Lead-in Period Day -1, 0.5 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.4","value":"14.5"},{"groupId":"OG001","spread":"22.9","value":"155"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Lead-in Period Day -1, 1 hour postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.8","value":"20.8"},{"groupId":"OG001","spread":"67.1","value":"211"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Lead-in Period Day -1, 2 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"6.56","value":"25.5"},{"groupId":"OG001","spread":"56.8","value":"246"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Lead-in Period Day -1, 3 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"13.1","value":"24.9"},{"groupId":"OG001","spread":"45.3","value":"231"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Lead-in Period Day -1, 4 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"38.1","value":"8.77"},{"groupId":"OG001","spread":"26.0","value":"147"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Lead-in Period Day -1, 5 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.2","value":"22.1"},{"groupId":"OG001","spread":"55.1","value":"223"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Lead-in Period Day -1, 6 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"5.81","value":"14.9"},{"groupId":"OG001","spread":"6.31","value":"168"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Lead-in Period Day -1, 8 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"12.8","value":"12.4"},{"groupId":"OG001","spread":"9.84","value":"130"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Lead-in Period Day -1, 12 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"27.4","value":"7.57"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Lead-in Period Day -1, 24 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"93.0","value":"147"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Cycle 1 Day 1, predose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"106","value":"14.1"},{"groupId":"OG001","spread":"85.5","value":"714"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Cycle 1 Day 8, predose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"254","value":"17.8"},{"groupId":"OG001","spread":"58.3","value":"620"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Cycle 1 Day 8, 0.5 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"307","value":"23.0"},{"groupId":"OG001","spread":"59.9","value":"637"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Cycle 1 Day 8, 1 hour postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"161","value":"43.2"},{"groupId":"OG001","spread":"86.9","value":"868"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Cycle 1 Day 8, 2 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"98.4","value":"71.7"},{"groupId":"OG001","spread":"89.6","value":"807"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Cycle 1 Day 8, 3 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"92.2","value":"73.6"},{"groupId":"OG001","spread":"77.1","value":"814"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Cycle 1 Day 8, 4 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"254","value":"17.8"},{"groupId":"OG001","spread":"58.3","value":"620"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Cycle 1 Day 8, 5 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"72.9","value":"68.9"},{"groupId":"OG001","spread":"81.3","value":"792"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Cycle 1 Day 8, 6 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"46.9","value":"55.8"},{"groupId":"OG001","spread":"82.8","value":"530"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Cycle 1 Day 8, 8 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"58.3","value":"43.6"},{"groupId":"OG001","spread":"97.5","value":"569"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Cycle 1 Day 8, 12 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"106","value":"14.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Cycle 1 Day 8, 24 hours postdose"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"43.8","value":"40.2"},{"comment":"The geometric coefficient of variation was not calculated for a single participant.","groupId":"OG001","spread":"NA","value":"443"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Cycle 2 Day 1, predose"},{"categories":[{"measurements":[{"comment":"One of the 2 observations was below the limit of quantification. Geometric coefficient of variation could not be calculated from a single measurable observation.","groupId":"OG000","spread":"NA","value":"53.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Cycle 4 Day 1, predose"},{"categories":[{"measurements":[{"comment":"The geometric coefficient of variation was not calculated for a single participant.","groupId":"OG000","spread":"NA","value":"25.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Cycle 6 Day 1, predose"}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"description":"During the lead-in period, INCB099280 was administered as monotherapy. During the treatment period, INCB099280 and adagrasib were coadministered.","dispersionType":"Geometric Coefficient of Variation","groups":[{"description":"Participants received INCB099280 50 milligrams (mg) once daily (QD) plus adagrasib 400 mg twice daily (BID) for up to 2 years.","id":"OG000","title":"INCB099280 50 mg QD Plus Adagrasib 400 mg BID"},{"description":"Participants received INCB099280 100 mg BID plus adagrasib 400 mg BID for up to 2 years.","id":"OG001","title":"INCB099280 100 mg BID Plus Adagrasib 400 mg BID"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"Pharmacokinetic (PK)-Evaluable Population: all participants who received at least 1 dose of INCB099280 and provided at least 1 postbaseline plasma sample (1 PK measurement)","reportingStatus":"POSTED","timeFrame":"Lead-in Period Day -1 and Cycle 1 Day 8: predose and 0.5, 1, 2, 3, 4, 6, 8, and 12 hours postdose; predose on Day 1 of Cycles 1, 2, 4, and 6","title":"Concentration of INCB099280","type":"SECONDARY","unitOfMeasure":"nanomoles (nM)"}